Drug Development Solutions Limited Company Profile

05:31 EDT 23rd September 2017 | BioPortfolio

Drug Development Solutions (DDS, formerly DDS Medicines Research) is one of the oldest UK-based Contract Research Organisations. We are independently owned and specialise in Phase I clinical trials, especially in First-In-Man and Phototoxicity studies. In more than 23 years, DDS has performed over 690 research studies, covering a wide range of pharmacokinetic and pharmacodynamic studies in all the major therapeutic areas.

We are located in Dundee, Scotland where we occupy a purpose built, 36-bed research unit adjoining Ninewells Hospital & Medical School, one of the largest hospital complexes in Europe. This location provides access to patient populations for Phase IIa efficacy studies (e.g. renal and hepatic impairment patients).


Ninewells Hospital & Medical School Patrick Blair Place
United Kingdom


Phone: 44 (0) 1382 646317
Fax: 44 (0) 1382 645606

News Articles [6875 Associated News Articles listed on BioPortfolio]

Piramal Pharma Solutions names John Fowler COO

Piramal Pharma Solutions (PPS), part of Piramal Enterprises Limited, announce the appointment of John Fowler as its Chief Operating Officer. PPS is a leader in Integrated Contract Development and Ma...

John Fowler Named COO of Piramal Pharma Solutions

Piramal Pharma Solutions (PPS) has appointed John Fowler as its Chief Operating Officer (COO). PPS is a leader in Integrated Contract Development and Manufacturing, with a global network of 12 develop...

MR Solutions brings preclinical MRI to World Preclinical Congress in Boston

MR Solutions will be showing their latest state of the art 3T to 9.4T superconducting, cryogen-free MRI imaging technology with optional PET and SPECT imaging modalities at the 16th annual World Precl...

Prescription Drug Use Skyrockets in Children, Experts Recommend Treatment Alternatives

NewsPrescription drugs for children skyrocket; integrated healthcare offers solutions.

China Joins Pursuit of Global Drug Development Standards

BlogDrug development is a global endeavor, requiring international collaboration to ensure that consistent standards are adopted and adhered to by all drug makers and regulatory authorities, regardles...

Drug Development at the Portfolio Level

This Viewpoint discusses the drug development portfolio—a family of trials assessing a drug for different indications or in different combinations with other drugs—and summarizes some of the chall...

Catalent to acquire biologics focused CDMO

Global provider of advanced delivery technologies and development solutions for drugs, Catalent, has reached an agreement to purchase Cook Pharmica, an integrated provider of drug substance and drug p...

Evotec to Pay $300M for Aptuit

Expands position as leading player in integrated outsourced drug discovery and development solutions

PubMed Articles [5953 Associated PubMed Articles listed on BioPortfolio]

Navigating the Future of Cardiovascular Drug Development-Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference.

The need for novel approaches to cardiovascular drug development served as the impetus to convene an open meeting of experts from the pharmaceutical industry and academia to assess the challenges and ...

Drug development for breast, colorectal, and non-small cell lung cancers from 1979 to 2014.

Understanding the drug development pathway is critical for streamlining the development of effective cancer treatments. The objective of the current study was to delineate the drug development timelin...

The potential of multi-compound nanoparticles to bypass drug resistance in cancer.

The therapeutic efficacy of conventional chemotherapy against several solid tumors is generally limited and this is often due to the development of resistance or poor delivery of the drugs to the tumo...

Combining hiPSCs and Human Genetics: Major Applications in Drug Development.

Merging iPSC models and human genetic research has opened up new avenues in understanding disease mechanisms and target biology, which facilitate exciting translation of this research to many areas of...

Current Challenges and Emerging Solutions in Upper GI Disorders: A Brief Report of the 2016 AGA Drug Development Conference.

Clinical Trials [3598 Associated Clinical Trials listed on BioPortfolio]

A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® Alone

To compare the effectiveness of a 90-day Copaxone® adherence enhancement program for a sample of MS patients who are at high risk of nonadherence and receive support from Shared Solutions...

TOnicity of Perioperative Maintenance SoluTions

Prospective randomized double blind phase IV trial studying the efficacy and safety of the tonicity of two different perioperative maintenance solutions: an isotonic solution containing Na...

Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness

Obesity is increasing at an alarming rate in patients with schizophrenia, possibly in association with the increased use of atypical antipsychotics. In order to address the weight and meta...

Palatability of Oral Rehydration Solutions

The primary objective of this study is to compare the mean taste scores for three fruit flavored oral rehydration solutions in children aged 5-10 years old. The secondary objective is to ...

FS-1 Drug for Treatment of Multiple Drug-resistant Tuberculosis

Drug-resistant tuberculosis is becoming a major problem for the whole humanity, and development of new Anti-TB drugs is of great importance. Since Kazakhstan is a country with the high bur...

Companies [4557 Associated Companies listed on BioPortfolio]


VASUDHA PHARMA CHEM LIMITED (VPCL) is a Company promoted by a team of accomplished technocrats for Bulk Drug industry with a total capital of Rupees 153 million ( US $ 5Million).All the promoters of V...

Embera NeuroTherapeutics, Inc.

Embera NeuroTherapeutics, Inc. is a development stage pharmaceutical company focused on treating a broad range of addictions and obesity where the major clinical challenge is a li...


GL CHEMTEC INTERNATIONAL is a skilled research, development, and manufacturing organization, specializing in contract research projects and in the custom synthesis of complex molecules. Our clients in...

Sentinel Oncology Limited

Sentinel Oncology was founded in 2005 with the vision of developing an innovative strategy for cancer treatment, ‘Targeted Synergy’ in which a single drug can be engineered to deliver tw...

Aizant Drug Research Solutions (P) Ltd

Aizant is established by individuals with over 30 years of pharmaceutical industrial experience in the USA. Aizant provides comprehensive drug development resources and solutions for Pre-formulation, ...

More Information about "Drug Development Solutions Limited" on BioPortfolio

We have published hundreds of Drug Development Solutions Limited news stories on BioPortfolio along with dozens of Drug Development Solutions Limited Clinical Trials and PubMed Articles about Drug Development Solutions Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Drug Development Solutions Limited Companies in our database. You can also find out about relevant Drug Development Solutions Limited Drugs and Medications on this site too.

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Corporate Database Quicklinks

Searches Linking to this Company Record